NCT06033521 - A Study to Learn More About the Menopausal Hormone Therapies in Korea | Biotech Hunter

Enrollment

1,036,294

Participants

Timeline

Start Date

September 12, 2023

Primary Completion Date

March 11, 2024

Study Completion Date

March 11, 2024

Conditions

MenopauseBone Demineralization

Interventions

DRUG

Menopausal hormone therapy Intervention Type: Drug

Subjects who were newly diagnosed menopausal symptoms between 01 Jan 2012 and 31 Dec 2019, and were followed up for 12 months at least in the HIRA claims database

Trial Locations (1)

Unknown

Pfizer South Korea, Seoul